Quick Answer
Sagimet Biosciences Inc. reported Net Income of -$51.04 million for fiscal year 2025.
Sagimet Biosciences Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$51.04M | -12.0% |
| 2024 | -$45.57M | -63.5% |
| 2023 | -$27.88M | +8.6% |
| 2022 | -$30.50M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$12.91M | +11.7% | -24.3% |
| June 30, 2025 | -$10.39M | -27.9% | +42.9% |
| March 31, 2025 | -$18.18M | -174.2% | -24.3% |
| September 30, 2024 | -$14.62M | -130.1% | -80.1% |
| June 30, 2024 | -$8.12M | -19.6% | -22.5% |
| March 31, 2024 | -$6.63M | -0.6% | -4.3% |
| September 30, 2023 | -$6.35M | +14.9% | +6.4% |
| June 30, 2023 | -$6.79M | +4.5% | -3.0% |
- Sagimet Biosciences Inc. showed a decrease of -12.0% in Net Income compared to the prior fiscal year.
- Over the 2022–2025 period, Sagimet Biosciences Inc.’s net income has declined by 67.3% (from -$30.50 million to -$51.04 million).
- The most recent figure is from Sagimet Biosciences Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 11, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: